Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
NCT00019604 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 44
Last updated 2017-02-03
Summary
RATIONALE: Radiofrequency ablation is a procedure that heats tumors to several degrees above body temperature and may kill tumor cells.
PURPOSE: Phase II trial to study the effectiveness of radiofrequency ablation in treating patients who have unresectable primary or metastatic liver cancer.
Conditions
- Liver Cancer
- Metastatic Cancer
- Unspecified Adult Solid Tumor, Protocol Specific
Interventions
- PROCEDURE
-
computed tomography
Scan to assess the effects of ablation.
- PROCEDURE
-
magnetic resonance imaging
Imaging used to assess the effects of this ablative therapy on tumor vascular density.
- PROCEDURE
-
positron emission tomography
Physiology based method of imaging disease based on uptake and metabolism of radiopharmaceutical by the tissues.
- PROCEDURE
-
radiofrequency ablation
Radiofrequency ablation uses saline infusion into and out of needle/electrode through a closed system. More energy may be deposited without tissue-charring or gas vaporization.
- PROCEDURE
-
radionuclide imaging
Imaging following injection of a radioactive material.
- PROCEDURE
-
ultrasound imaging
An ultrasound (e.g. sound waves) is used to identify the lesion and needle placement.
- RADIATION
-
fludeoxyglucose F 18 (FDG-PET)
FDG PET scans rely on metabolic changes to evaluate response to therapy.
- RADIATION
-
gadopentetate dimeglumine
Food and Drug Administration approved contrast agent.
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
National Institutes of Health Clinical Center (CC)
lead NIH
Principal Investigators
-
Steven A Libutti, MD · National Cancer Institute, National Institutes of Health
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1998-08-31
- Primary Completion
- 2009-01-31
- Completion
- 2009-01-31
Countries
- United States
Study Locations
More Related Trials
-
Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases
NCT00510627 ·Status: WITHDRAWN ·Phase: PHASE4
-
Radiofrequency Ablation Plus Radiotherapy for Small Hepatocellular Carcinoma
NCT03988998 ·Status: UNKNOWN ·Phase: PHASE3
-
Radiofrequency Ablation Using Cooled-Wet Electrode
NCT02675894 ·Status: COMPLETED ·Phase: NA
-
Microwave Ablation for the Treatment of Malignant Liver Tumors Closed to Intrahepatic Vessels
NCT03063840 ·Status: WITHDRAWN ·Phase: NA
-
Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation (RFA) Associated With Postoperative TACE
NCT00730860 ·Status: UNKNOWN ·Phase: NA
-
Study of Saline Linked Monopolar Surface Radiofrequency (RF) Ablation of Hepatic Tumors
NCT00869843 ·Status: COMPLETED ·Phase: PHASE1
-
Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer
NCT06766643 ·Status: RECRUITING ·Phase: PHASE2
-
Comparison of Microwave and Radiofrequency Ablation for Liver
NCT02539212 ·Status: COMPLETED ·Phase: NA
-
Radiofrequency Ablation Combined With S-1 for Pancreatic Cancer With Liver Metastasis
NCT02634502 ·Status: UNKNOWN ·Phase: PHASE2
-
To Evaluate the Safety and Efficacy of Microwave Ablation Therapy in Patients With Primary Liver Cancer
NCT04520906 ·Status: TERMINATED ·Phase: NA
-
Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function
NCT02626312 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular Carcinoma
NCT00554905 ·Status: UNKNOWN ·Phase: PHASE4
-
Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer
NCT00813293 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Stereotactic Radiosurgery For Liver Malignancies
NCT00230347 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of Microwave Ablation of Hepatocellular Carcinoma as Compared to Radiofrequency Ablation
NCT01340105 ·Status: COMPLETED ·Phase: NA
-
Combination Chemoembolization and Stereotactic Body Radiation Therapy in Unresectable Hepatocellular Carcinoma
NCT02513199 ·Status: COMPLETED ·Phase: PHASE2
-
Radiofrequency Ablation Combined With Recombinant Human Adenovirus Type 5 in the Treatment of Hepatocellular Carcinoma.
NCT03790059 ·Status: UNKNOWN ·Phase: NA
-
Immune Profile and Prognosis of Malignant Liver Tumors With Radiofrequency Ablation (RFA) Therapy
NCT04707547 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy
NCT05551299 ·Status: RECRUITING ·Phase: PHASE4
-
Radiofrequency Ablation Assisted Hepatectomy Versus Hepatectomy Alone for Advanced Hepatocellular Carcinoma
NCT01713244 ·Status: UNKNOWN ·Phase: NA
-
Hepatectomy Versus Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to Major Blood Vessels
NCT00814242 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Cryosurgery in Treating Patients With Liver Cancer or Liver Metastases
NCT00002655 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety, Efficacy, and Immune Response of Multimodal Thermal Therapy in the Treatment of Malignant Liver Tumors
NCT07159048 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Clinical Study of Targeted Cryoablation Therapy in the Treatment of Hepatic Carcinoma
NCT02969096 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase I Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver Metastases
NCT00185874 ·Status: TERMINATED ·Phase: PHASE1